Penicillin treatment of syphilis: Clearing away the shadow on the land

JAMA

Volumn 301, Issue 7, 2009, Pages 769-771

  Douglas, John M ^a   Mahoney, J F ^a   Arnold, R C ^a   Sterner, Burton L ^a   Moore, J E ^a   Schwartz, W ^a,a   Stokes, J H ^a   Sternberg, T H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; PENICILLIN G; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; BACTERIAL TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; NOTE; PRIORITY JOURNAL; SYPHILIS; UNITED STATES; ARTICLE; HISTORY; MORTALITY; PENICILLIN RESISTANCE; TREPONEMA PALLIDUM;

ANTI-BACTERIAL AGENTS; HISTORY, 20TH CENTURY; HUMANS; PENICILLIN RESISTANCE; PENICILLINS; SYPHILIS; TREPONEMA PALLIDUM;

EID: 60749115999     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.143     Document Type: Note

References (16)

1. Mahoney JF, Arnold RC, Sterner BL, et al. Penicillin treatment of early syphilis. JAMA. 1944;126(2):63-67.
2. Moore JE, Mahoney JF, Schwartz W, et al. The treatment of early syphilis with penicillin. JAMA. 1944;126(2):67-73.
3. Stokes JH, Sternberg T, Schwartz W, et al. The action of penicillin in late syphilis. JAMA. 1944;126(2):73-80.
4. Sparling PF, Swartz MN, Musher DM, et al. Clinical manifestations of syphilis. In: Holmes KK, ed. Sexually Transmitted Disease. 4th ed. New York, NY: McGraw-Hill; 2007:661-684.
5. Parran T. Shadow on the Land: Syphilis. New York, NY: American Social Hygiene Association; 1937.
6. Tramont EC. Treponema pallidum (syphilis). In: Mandell GL, Bennett JE, Raphael D, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier; 2005:2768-2785.
7. Fenton KA, Breban R, Vardavas R, et al. Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis. 2008;8(4):244-253.
8. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2006. Atlanta, GA: US Dept of Health and Human Services; November 2007.
9. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281(1):61-66.
10. Douglas JM Jr, Peterman TA, Fenton KA. Syphilis among men who have sex with men: challenges to syphilis elimination in the United States. Sex Transm Dis. 2005;32(10)(suppl):S80-S83.
11. White RG, Orroth KK, Korenromp EL, et al. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials? a modeling study. J Acquir Immune Defic Syndr. 2004;37(4):1500-1513.
12. Peeling RW, Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bull World Health Organ. 2004;82(6): 439-446.
13. Bai ZG, Yang KH, Liu YL, et al. Azithromycin vs. benzathine penicillin G for early syphilis: a meta-analysis of randomized clinical trials. Int J STD AIDS. 2008; 19(4):217-221.
14. Schmid GP, Stoner BP, Hawkes S, Broutet N. The need and plan for global elimination ofcongenital syphilis. Sex Transm Dis. 2007;34(7)(suppl):S5- S10.
15. Borisenko KK, Tichonova LI, Renton AM. Syphilis and other sexually transmitted infections in the Russian Federation. Int J STD AIDS. 1999;10(10):665-668.
16. Chen ZQ, Zhang GC, Gong XD, et al. Syphilis in China: results of a national surveillance programme. Lancet. 2007;369(9556):132-138.